FDA Investigator Jeanne J Thai

Jeanne J Thai has conducted inspections on 156 sites in 12 countries as of 06 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
156
Last Inspection Date:
06 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Poland, Netherlands, Chile, India, Spain, Austria, Canada, Italy, Malaysia, Israel, Korea (Republic of)
FDA Investigators that have inspected at least one site in common with Jeanne J Thai:
Adam J Taylor, Adam M True, Alan M Barker, Alan M Roberts, Alanna L Mussawwir Bias, Alicia M Mozzachio, Alla Dubrovsky, Amanda B Athey, Amanda E Lewin, PhD, Amanda S Zorn, Amy Kim, Ana L Kewes, Anastasia I Onuorah, Andrew J Barrowcliff, Arindam Dasgupta, PhD, Audrey Dela Cruz, Barbara D Wright, Barbara G Langer, Betsy C Galliher, Bonnie E Conley, Bonnie E Pierson, Bradley J Maunder, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carolyn A Volpe, CDR Rochelle B Young, RPh, MSA, Charles A Snipes, PhD, Chase S Baldwin, Cheryl A Grandinetti, Christina A Miller, Christopher D Leach, Colleen E Burke, Courtney N Long, Craig A Garmendia, Cynthia Jim, CSO, Daniel B Bordt, Dariusz Galezowski, Darla J Christopher, Dawn C Olenjack, Debra I Love, Debra Lboyd Seale, Decarlos A Gomez, Denarvis C Mendenhall, Denise L Burosh, Donna D Gallien, MPH, Donna K Speer, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Elizabeth L Holmes, Elyshia Q Danaher, Emily S Mcgann, Eric M Mueller, PharmD, Eric S Pittman, Erin M Mcdowell, Esther A Ofori, Gabrielle J Swain, Gabryelle J Solverud, Gene D Arcy, Gloria A Milster, Gregory R Dill, Hanna L Potter, Hasan A Irier, PhD, Hoimay Chan, Humera T Khan, Irina Gaberman, James L Finn, James P Duggan, James W Plucinski, Janae D Price, Jasmine Y Wang, Jason F Chancey, Jeanne J Chiu, Jeanne M Morris, Jennifer A D'angelo, Jennifer C Adams, Jennifer C Johnson, Jesse A Vazquez, Joan A Loreng, Jocelyn C Turner, John A Iwen, Jonathan R Campos, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Julian C Hanson, Kara A Scheibner, PhD, Karen Emasley Joseph, Karen M Montgomery (KMM), Kathleen A Schelble, Kathleen S Tormey, Kellia N Hicks, Kenneth L Smalls, Kimberly A Dutzek, Kristin M Abaonza, Kujtim Sadiku, Lacey J Chessor, Lacey J Rice, Lan T Tran, Lana K Waselewski, Lance Mde Souza, MBA, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Lauren N Howard, Laurie A Haxel, Lavender M Huskey, Laverne Puckett, LCDR Ismael Olvera, IV, Lee Terry Moore, Leighton Kn Gai, Lequita M Mayhew, Leslie D Hintz, Lewis K Antwi, Li Hongpaul Yeh, PhD, Linh Tu, Lisa Hayka, Lisa Hornback, Lorelei S Jarrell, Lori A Gioia, Lucila B Nwatu, Lynda L Lanning, M A Abel I, Makini Cobourne Duval, PhD, Marcia A Worley, Margaret Torres Vazquez, Maria Diaz, Mark C Saale, Mark I Kaspar, Matthew J Gretkierewicz, Matthew J Sienko, Melkamu Getie Kebtie, PhD, Michael D Robinson, Michael P Anthony, Michele L Glendenning, Michele Perry Williams, Min Chu Chen, Muhammad Naiman, Myra K Casey, Nancy A Bellamy, Natasha R Johnson, Nathan R Moon, Nicholas P Diorio, Nicholas Z Lu, Nicole C Victoria, PhD, Nicole S Williams, Pablo Alcantara, Pankaj H Amin, Patricia A Mcilroy, Patrick E Gainer, Paul M Chefor, Paula P Demichael, Peng Zhou, Phung Thien Nguyen, Prajakta A Varadkar, Rachel E Mcguigan, Rafael Padilla, Randy D Baxter, Raymond W Brullo, Robert J Ham, Roberta W Cunningham, Ronda Rloyd Jones, Rosemary Wood Sexton, Ruben C Ayala, PharmD, Russell K Riley, Ruth A Williams, Samuel W Labinjo, Sandra S Saniga, Sarah Nwandiuko, Scott B Laufenberg, Shalonda C Clifford, Sherri J Jackson, Sripal R Mada, PhD, Sullan, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan M North, Susan W Ciani, Tara A Marshall, Tara C Alcazar, Teena H Aiken, Tenzin Jangchup, Thea C Grome, Theressa B Smith, Thomas J Arista, Thunder N Dunkijacobs, Todd M Stankewicz, Tong Zhou, Travis S Bradley, Uruaku A Obasi, Vaishali J Patel, Wayne W Grundstrom, William F Lagud, Jr, William R Weissinger, William V Millar, Yangmin Ning, Yiyue Zhang (nmi), PhD, Yuanyuan Li, Zerita White, Zoey A Trombley

Jeanne J Thai's Documents

Publish Date Document Type Title
July, 2019 EIR Charles River Laboratories Ashland, LLC - EIR, 2019-07-26
September, 2019 FDA 483 Sukit Christopher Malaisrie, M.D. - Form 483, 2019-09-04
March, 2023 FDA 483 Experimur, A Frontage Company - Form 483, 2023-03-10
May, 2021 FDA 483 CellTrans Inc. - Form 483, 2021-05-06
April, 2021 FDA 483 Ning Z. Wu, M.D. - Form 483, 2021-04-13
March, 2022 FDA 483 Maria L. Colavincenzo, M.D. - Form 483, 2022-03-10
October, 2021 EIR Veeral S. Sheth, M.D. - EIR, 2021-10-08
May, 2022 FDA 483 Shuo Ma, M.D. - Form 483, 2022-05-06
June, 2022 FDA 483 AltaThera Pharmaceuticals LLC - Form 483, 2022-06-17
May, 2013 FDA 483 Valentino, Leonard A. Dr. - Form 483, 2013-05-29
September, 2019 EIR Lovelace Biomedical Research Institute - EIR, 2019-09-13
April, 2023 FDA 483 Priya U. Kumthekar, M.D. - Form 483, 2023-04-28
June, 2021 FDA 483 Sunandana Chandra, M.D. - Form 483, 2021-06-16
April, 2019 FDA 483 Glen Sussman - Form 483, 2019-04-12
July, 2019 FDA 483 Charles River Laboratories Ashland, LLC - Form 483, 2019-07-26
June, 2015 FDA 483 Response Demetrius K. Lopes, M.D. - Form 483R, 2015-12-18
June, 2022 EIR AltaThera Pharmaceuticals LLC - EIR, 2022-06-17
January, 2022 FDA 483 Manish Jain, M.D. - Form 483, 2022-01-24
December, 2021 EIR AbbVie Inc. - EIR, 2021-12-15
June, 2015 EIR Demetrius K. Lopes, M.D. - EIR, 2015-06-25
December, 2023 FDA 483 IIT Research Institute - Form 483, 2023-12-01
June, 2015 FDA 483 Demetrius K. Lopes, M.D. - Form 483, 2015-06-25
October, 2019 EIR Astellas Pharma US Inc. - EIR, 2019-10-04
October, 2019 FDA 483 Response Astellas Pharma US Inc. - Form 483R, 2019-10-24
July, 2019 FDA 483 Response Charles River Laboratories Ashland, LLC - Form 483R, 2019-08-14
September, 2019 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2019-09-13
May, 2013 FDA 483 Response Valentino, Leonard A. Dr. - Form 483R, 2013-06-17

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more